Direct induction of ramified microglia-like cells from human monocytes: Dynamic microglial dysfunction in Nasu-Hakola disease
Citations Over TimeTop 10% of 2014 papers
Abstract
Microglia have been implicated in various neurological and psychiatric disorders in rodent and human postmortem studies. However, the dynamic actions of microglia in the living human brain have not been clarified due to a lack of studies dealing with in situ microglia. Herein, we present a novel technique for developing induced microglia-like (iMG) cells from human peripheral blood cells. An optimized cocktail of cytokines, GM-CSF and IL-34, converted human monocytes into iMG cells within 14 days. The iMG cells have microglial characterizations; expressing markers, forming a ramified morphology, and phagocytic activity with various cytokine releases. To confirm clinical utilities, we developed iMG cells from a patient of Nasu-Hakola disease (NHD), which is suggested to be directly caused by microglial dysfunction, and observed that these cells from NHD express delayed but stronger inflammatory responses compared with those from the healthy control. Altogether, the iMG-technique promises to elucidate unresolved aspects of human microglia in various brain disorders.
Related Papers
- → Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients(2021)161 cited
- → Efficient Strategies for Microglia Replacement in the Central Nervous System(2020)157 cited
- → Microglia in multiple sclerosis: Protectors turn destroyers(2022)155 cited
- → Microglia derived from the axotomized adult rat facial nucleus uptake glutamate and metabolize it to glutamine in vitro(2016)6 cited
- Contributions of Microglia in the Healthy and Injured Brain(2015)